PTC Therapeutics, Inc. (PTCT) vs Travere Therapeutics, Inc. (TVTX)
- PTC Therapeutics, Inc. PTCT 59.24 −2.87%
- Travere Therapeutics, Inc. TVTX 49.62 −6.00%
PTC Therapeutics, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. PTC Therapeutics, Inc. and Travere Therapeutics, Inc. are of similar size ($5.1B and $5.0B). Travere Therapeutics, Inc. grew revenue faster over the last twelve months: 77.1% against −42.8%. PTC Therapeutics, Inc. has the higher net margin (−3.80% vs −7.35%) and the higher return on invested capital (15.2% vs −18.3%). Across the 18 metrics below, PTC Therapeutics, Inc. leads on 13 and Travere Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | PTCT | TVTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.99% | 98.60% | 65.16% |
| Operating margin | 12.45% | (6.84%) | 0.00% |
| Net margin | (3.80%) | (7.35%) | 0.00% |
| Free cash flow margin | (29.76%) | 2.56% | 0.00% |
| Return on equity | 20.64% | (151.79%) | (56.36%) |
| Return on assets | (1.30%) | (6.42%) | (48.04%) |
| Return on invested capital | 15.16% | (18.31%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack